These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 29275593)
1. [Impact on the incidence of postoperative ventricular arrhythmias after cardiac resynchronization therapy defibrillator with quadripolar lead]. Wu GH; Chen KY; Yu F; Wang Q; Xu J; Su H; Yang DM; Yan J Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3548-3552. PubMed ID: 29275593 [No Abstract] [Full Text] [Related]
2. Cost-Effectiveness Analysis of Quadripolar Versus Bipolar Left Ventricular Leads for Cardiac Resynchronization Defibrillator Therapy in a Large, Multicenter UK Registry. Behar JM; Chin HM; Fearn S; Ormerod JO; Gamble J; Foley PW; Bostock J; Claridge S; Jackson T; Sohal M; Antoniadis AP; Razavi R; Betts TR; Herring N; Rinaldi CA JACC Clin Electrophysiol; 2017 Feb; 3(2):107-116. PubMed ID: 28280785 [TBL] [Abstract][Full Text] [Related]
3. Impact of quadripolar LV leads on heart failure hospitalization rates among patients implanted with CRT-D: data from the Israeli ICD Registry. Leshem E; Suleiman M; Laish-Farkash A; Haim M; Geist M; Luria D; Glikson M; Goldenberg I; Michowitz Y; J Interv Card Electrophysiol; 2018 Jan; 51(1):5-12. PubMed ID: 29274032 [TBL] [Abstract][Full Text] [Related]
4. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders. Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504 [TBL] [Abstract][Full Text] [Related]
5. Effect of Continued Cardiac Resynchronization Therapy on Ventricular Arrhythmias After Left Ventricular Assist Device Implantation. Schleifer JW; Mookadam F; Kransdorf EP; Nanda U; Adams JC; Cha S; Pajaro OE; Steidley DE; Scott RL; Carvajal T; Saadiq RA; Srivathsan K Am J Cardiol; 2016 Aug; 118(4):556-9. PubMed ID: 27328958 [TBL] [Abstract][Full Text] [Related]
6. Hospitalization rates and associated cost analysis of cardiac resynchronization therapy with an implantable defibrillator and quadripolar vs. bipolar left ventricular leads: a comparative effectiveness study. Forleo GB; Di Biase L; Bharmi R; Dalal N; Panattoni G; Pollastrelli A; Tesauro M; Santini L; Natale A; Romeo F Europace; 2015 Jan; 17(1):101-7. PubMed ID: 25371428 [TBL] [Abstract][Full Text] [Related]
7. Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial. Sapp JL; Parkash R; Wells GA; Yetisir E; Gardner MJ; Healey JS; Thibault B; Sterns LD; Birnie D; Nery PB; Sivakumaran S; Essebag V; Dorian P; Tang AS Circ Arrhythm Electrophysiol; 2017 Mar; 10(3):. PubMed ID: 28292754 [TBL] [Abstract][Full Text] [Related]
8. Safety of magnetic resonance imaging scanning in patients with cardiac resynchronization therapy-defibrillators incorporating quadripolar left ventricular leads. Rinaldi CA; Vitoff PJ; Nair DG; Bernstein R; Mountantonakis SE; Rapacciuolo A; Carter N; Tse HF; Green UB Heart Rhythm; 2020 Dec; 17(12):2064-2071. PubMed ID: 32911050 [TBL] [Abstract][Full Text] [Related]
9. Impact of cardiac resynchronization therapy on clinical outcomes in patients with continuous-flow left ventricular assist devices. Gopinathannair R; Birks EJ; Trivedi JR; McCants KC; Sutton BS; Deam AG; Slaughter MS; Hottigoudar RU J Card Fail; 2015 Mar; 21(3):226-32. PubMed ID: 25528199 [TBL] [Abstract][Full Text] [Related]
10. Improved implant and postoperative lead performance in CRT-D patients implanted with a quadripolar left ventricular lead. A 6-month follow-up analysis from a multicenter prospective comparative study. Forleo GB; Di Biase L; Panattoni G; Mantica M; Parisi Q; Martino A; Pappalardo A; Sergi D; Tesauro M; Papavasileiou LP; Santini L; Calò L; Tondo C; Natale A; Romeo F J Interv Card Electrophysiol; 2015 Jan; 42(1):59-66. PubMed ID: 25504267 [TBL] [Abstract][Full Text] [Related]
11. Impact of QRS Duration and Ventricular Pacing on Clinical and Arrhythmic Outcomes in Continuous Flow Left Ventricular Assist Device Recipients: A Multicenter Study. Gopinathannair R; Roukoz H; Trivedi JR; Cowger J; Bhan A; Ravichandran A; Bhat G; Birks EJ; Slaughter MS; Ahmed MM J Card Fail; 2019 May; 25(5):355-363. PubMed ID: 30797964 [TBL] [Abstract][Full Text] [Related]
12. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study. Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882 [TBL] [Abstract][Full Text] [Related]
13. Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis. Barra S; Duehmke R; Providencia R; Marijon E; Boveda S; Virdee M; Heck P; Fynn S; Begley D; Grace A; Agarwal S Europace; 2018 Jan; 20(1):89-96. PubMed ID: 28031276 [TBL] [Abstract][Full Text] [Related]
14. Cardiac Resynchronization Therapy Delivered Via a Multipolar Left Ventricular Lead is Associated with Reduced Mortality and Elimination of Phrenic Nerve Stimulation: Long-Term Follow-Up from a Multicenter Registry. Behar JM; Bostock J; Zhu Li AP; Chin HM; Jubb S; Lent E; Gamble J; Foley PW; Betts TR; Rinaldi CA; Herring N J Cardiovasc Electrophysiol; 2015 May; 26(5):540-6. PubMed ID: 25631303 [TBL] [Abstract][Full Text] [Related]
15. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D. Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954 [TBL] [Abstract][Full Text] [Related]
16. Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis. Yuyun MF; Erqou SA; Peralta AO; Hoffmeister PS; Yarmohammadi H; Echouffo Tcheugui JB; Martin DT; Joseph J; Singh JP Europace; 2021 Aug; 23(8):1262-1274. PubMed ID: 33496319 [TBL] [Abstract][Full Text] [Related]
17. Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators. Kawamura M; Arai S; Yoshikawa K; Gokan T; Ogawa K; Ochi A; Onishi Y; Munetsugu Y; Ito H; Onuki T; Kobayashi Y; Shinke T Clin Cardiol; 2019 Jul; 42(7):670-677. PubMed ID: 31056759 [TBL] [Abstract][Full Text] [Related]
18. Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial. Gasparini M; Proclemer A; Klersy C; Kloppe A; Lunati M; Ferrer JB; Hersi A; Gulaj M; Wijfels MC; Santi E; Manotta L; Arenal A JAMA; 2013 May; 309(18):1903-11. PubMed ID: 23652522 [TBL] [Abstract][Full Text] [Related]
19. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
20. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only. Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]